Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy

Abstract Purpose In patients with neuroendocrine tumor liver metastases, additional tumor reduction can be achieved by sequential treatment with [166Ho]-radioembolization after peptide receptor radionuclide therapy (PRRT). The aim of this study was to analyze hematotoxicity profiles, (i.e. lymphocyt...

Full description

Bibliographic Details
Main Authors: Sander C. Ebbers, Tessa Brabander, Margot E. T. Tesselaar, Johannes Hofland, Manon N. G. J. A. Braat, Frank J. Wessels, Maarten W. Barentsz, Marnix G. E. H. Lam, Arthur J. A. T. Braat
Format: Article
Language:English
Published: SpringerOpen 2022-02-01
Series:EJNMMI Research
Subjects:
PRRT
NET
Neuroendocrine tumor
Neuroendocrine neoplasm
Lutetium-177-dotatate
Radioembolization
Online Access:https://doi.org/10.1186/s13550-022-00880-4

Internet

https://doi.org/10.1186/s13550-022-00880-4

Similar Items